UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Preoperative chemotherapy for non-small cell lung cancer: a systematic review and meta-analysis of individual participant data

NSCLC Meta-analysis Collaborative Group, The; (2014) Preoperative chemotherapy for non-small cell lung cancer: a systematic review and meta-analysis of individual participant data. Lancet , 383 (9928) pp. 1561-1571. 10.1016/S0140-6736(13)62159-5. Green open access

[thumbnail of 1-s2.0-S0140673613621595-main.pdf]
Preview
PDF
1-s2.0-S0140673613621595-main.pdf

Download (435kB)
[thumbnail of Table 1.      Trial characteristics] Excel Spreadsheet (Table 1. Trial characteristics)
Preoperative_chemotherapy_table.csv

Download (3kB)
[thumbnail of     Table 2.      Characteristics of included patients] Excel Spreadsheet ( Table 2. Characteristics of included patients)
Preoperative_chemotherapy_table_1.csv

Download (798B)
[thumbnail of GIF Figure 1.   Effect of preoperative chemotherapy on survival]
Preview
Other (GIF Figure 1. Effect of preoperative chemotherapy on survival)
Preoperative_chemotherapy_science.gif

Download (244kB)
[thumbnail of JPG Figure 2.   Kaplan-Meier curves (non-stratified) of the effect of preoperative chemotherapy on time to survival]
Preview
Other (JPG Figure 2. Kaplan-Meier curves (non-stratified) of the effect of preoperative chemotherapy on time to survival)
Preoperative_chemotherapy_science_1.jpg

Download (276kB)
[thumbnail of     Table 3.      Effect of preoperative chemotherapy by prespecified trial group] Excel Spreadsheet ( Table 3. Effect of preoperative chemotherapy by prespecified trial group)
Preoperative_chemotherapy_table_2.csv

Download (3kB)
[thumbnail of GIF Figure 3.   Forest plot of the interactions between the effect of preoperative chemotherapy on survival and covariates]
Preview
Other (GIF Figure 3. Forest plot of the interactions between the effect of preoperative chemotherapy on survival and covariates)
Preoperative_chemotherapy_science_2.gif

Download (317kB)
[thumbnail of JPG Figure 4.   Kaplan-Meier curves (non-stratified) of the effect of preoperative chemotherapy on time to distant and locoregional recurrence and recurrence-free survival]
Preview
Other (JPG Figure 4. Kaplan-Meier curves (non-stratified) of the effect of preoperative chemotherapy on time to distant and locoregional recurrence and recurrence-free survival)
Preoperative_chemotherapy_science_3.jpg

Download (741kB)

Abstract

BACKGROUND: Individual participant data meta-analyses of postoperative chemotherapy have shown improved survival for patients with non-small-cell lung cancer (NSCLC). We aimed to do a systematic review and individual participant data meta-analysis to establish the effect of preoperative chemotherapy for patients with resectable NSCLC. METHODS: We systematically searched for trials that started after January, 1965. Updated individual participant data were centrally collected, checked, and analysed. Results from individual randomised controlled trials (both published and unpublished) were combined using a two-stage fixed-effect model. Our primary outcome, overall survival, was defined as the time from randomisation until death (any cause), with living patients censored on the date of last follow-up. Secondary outcomes were recurrence-free survival, time to locoregional and distant recurrence, cause-specific survival, complete and overall resection rates, and postoperative mortality. Prespecified analyses explored any variation in effect by trial and patient characteristics. All analyses were by intention to treat. FINDINGS: Analyses of 15 randomised controlled trials (2385 patients) showed a significant benefit of preoperative chemotherapy on survival (hazard ratio [HR] 0.87, 95% CI 0.78-0.96, p=0.007), a 13% reduction in the relative risk of death (no evidence of a difference between trials; p=0.18, I2=25%). This finding represents an absolute survival improvement of 5% at 5 years, from 40% to 45%. There was no clear evidence of a difference in the effect on survival by chemotherapy regimen or scheduling, number of drugs, platinum agent used, or whether postoperative radiotherapy was given. There was no clear evidence that particular types of patient defined by age, sex, performance status, histology, or clinical stage benefited more or less from preoperative chemotherapy. Recurrence-free survival (HR 0.85, 95% CI 0.76-0.94, p=0.002) and time to distant recurrence (0.69, 0.58-0.82, p<0.0001) results were both significantly in favour of preoperative chemotherapy although most patients included were stage IB-IIIA. Results for time to locoregional recurrence (0.88, 0.73-1.07, p=0.20), although in favour of preoperative chemotherapy, were not statistically significant. INTERPRETATION: Findings, which are based on 92% of all patients who were randomised, and mainly stage IB-IIIA, show preoperative chemotherapy significantly improves overall survival, time to distant recurrence, and recurrence-free survival in resectable NSCLC. The findings suggest this is a valid treatment option for most of these patients. Toxic effects could not be assessed. FUNDING: Medical Research Council UK

Type: Article
Title: Preoperative chemotherapy for non-small cell lung cancer: a systematic review and meta-analysis of individual participant data
Open access status: An open access version is available from UCL Discovery
DOI: 10.1016/S0140-6736(13)62159-5
Publisher version: http://dx.doi.org/10.1016/S0140-6736(13)62159-5
Language: English
Additional information: Copyright © 2014 NSCLC Meta-analysis Collaborative Group. Open Access article distributed under the terms of CC BY (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Inst of Clinical Trials and Methodology
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Inst of Clinical Trials and Methodology > MRC Clinical Trials Unit at UCL
URI: https://discovery.ucl.ac.uk/id/eprint/1427140
Downloads since deposit
4,691Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item